VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
46,870MODERNA
532GLAXOSMITHKLINE BIOLOGICALS
353PFIZER\BIONTECH
231MERCK & CO. INC.
221UNKNOWN MANUFACTURER
62SEQIRUS, INC.
25DYNAVAX TECHNOLOGIES CORPORATION
13EMERGENT BIOSOLUTIONS
12SANOFI PASTEUR
9NOVARTIS VACCINES AND DIAGNOSTICS
5PFIZER\WYETH
5PAXVAX
2TEVA PHARMACEUTICALS
2PROTEIN SCIENCES CORPORATION
1BERNA BIOTECH, LTD.
1INTERCELL AG
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL1,906
1,575
289
IMM209286
252
236
229
s029456178
171
UT7065MA166
155
149
145
S034636133
107
U62828AA103
100
98
P10025327596
U6737AA85
UJ446AA79
78
78
59
57
4BH3254
4F47253
52
27656352
50
PP9L548
49TM346
42
40
38
MENVEO38
4F47237
R1B252M36
34
C5763AA30
93362229
25
300057A24
UNK24
22
CW311621
18
17
15
UH894AB15
3Y7NL12
R1B743M12
EJ168611
el128410
10
10
10
9
ARBA141A9
UNK9
8
UNK8
8
1F4EB8
Unknown7
7
No batch number6
5
5
UJ090AA5
5
5
4
4
4
UNK4
JEV18K95E4
UNK3
A115A3
Z127A3
3
3333324181073
2
2
2
TAR352
1
1
1
1
1
A739081
1
1
1
1
1
037K20A68,542
EL128447,700
133

Incidents per State

State Total
15,185
CA14,096
NY7,507
TX7,196
FL6,939
IN5,527
PA4,560
IL4,179
OH4,054
AZ3,856
MI3,771
NJ3,411
MA3,278
VA3,208
NC3,114
WA3,034
GA2,864
MD2,652
MN2,534
CO2,532
WI2,457
MO2,029
OR1,943
TN1,715
CT1,693
KY1,603
OK1,226
AL1,201
KS1,162
IA1,157
SC1,106
NM1,065
UT973
AR951
LA945
NE829
NV797
ME795
MT789
NH756
ID674
AK661
WV661
PR650
MS585
HI536
RI510
VT441
SD361
ND356
DE350
DC239
WY209
GU32
AS16
VI13
MP9
MH3
FM2
QM1
XB1

ID: 0945912
Sex: F
Age:
State: IL

Vax Date: 01/07/2021
Onset Date: 01/08/2021
Rec V Date: 01/15/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Fever; chills; muscle aches; headache; fatigue; This is a spontaneous report from a contactable nurse (patient). This 51--year-old female nurse reported for herself received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) (lot number: EL1283/expiration date: unknown), via unknown route of administration, on 07Jan2021at 12:00 PM (at the age of 51 years old) as a single dose in the left arm for COVID-19 immunization at workplace clinic. Relevant medical history included chronic Fatigue. The patient have known allergies to penicillin (PCN). Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included ferrous sulfate 65 mg, daily. The patient previously received the first dose of BNT162B2 (lot number: EJ1685/expiration date: unknown) on 17Dec2020 at 01:00 PM (at the age of 51 years old) as a single dose in the left arm via unknown route of administration for COVID-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 08Jan2021 at 12:00 AM, after the second dose, the patient experienced fever, chills, muscle aches, headache, fatigue. No treatment was received for the events fever, chills, muscle aches, headache, fatigue. The outcome of the events fever, chills, muscle aches, headache, fatigue was unknown. The patient was not pregnant at the time of vaccination. Since the vaccination, the patient had not been tested for COVID-19.

Other Meds:

Current Illness:

ID: 0945913
Sex: F
Age:
State: NC

Vax Date: 12/18/2020
Onset Date:
Rec V Date: 01/15/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Lightheaded; flushed; This is a spontaneous report from a contactable pharmacist. A 47-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscular on 18Dec2020 (Batch/lot number: EJ1685) at a single dose on left arm, and received the second dose, intramuscular on 08Jan2021 (Batch/lot number: EK9231) at a single dose on left arm for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced lightheaded and flushed on an unspecified date. Treatment not received for the adverse events. The outcome of the events was recovering. The events were assessed as non-serious. The patient was not pregnant at the time of vaccination. Facility where the most recent COVID-19 vaccine was administered was Hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19.

Other Meds:

Current Illness:

ID: 0945914
Sex: F
Age:
State: CA

Vax Date: 01/05/2021
Onset Date: 01/06/2021
Rec V Date: 01/15/2021
Hospital:

Lab Data:

Allergies:

Symptoms: chills; fever; intense body pain all over; headache; nausea; This is a spontaneous report from a contactable nurse (patient). A 62-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3249), via an unspecified route of administration on 05Jan2021 17:30 in right arm at single dose for COVID-19 immunization. Medical history included hypopituitarism from an unknown date and unknown if ongoing. The patient received first dose of BNT162B2 (lot number: EJ1685), on 18Dec2020 10:45 in left arm at single dose. Concomitant medication included second dose of varicella zoster vaccine rge (cho) (SHINGRIX) for immunization, hydrocortisone acetate (CORTEF), levothyroxine sodium (SYNTHROID), desmopressin acetate (DDAVP), simvastatin, estrogens conjugated, medroxyprogesterone acetate (PREMPRO) and losartan potassium (LO). On 06Jan2021 08:00, the patient experienced chills, fever, intense body pain all over, headache and nausea. No treatment was given to the patient for the events. The patient recovered from the events in Jan2021. The facility where the most recent COVID-19 vaccine was administered was in the hospital. The patient received SHINGRIX within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The events were considered non serious as it did not result in death, was not life threatening, did not cause/prolonged hospitalization, was not disabling/Incapacitating and had no congenital anomaly/birth defect.

Other Meds: CORTEF [HYDROCORTISONE ACETATE]; SYNTHROID; DDAVP; ; PREMPRO; LO

Current Illness:

ID: 0945915
Sex: M
Age:
State: NE

Vax Date: 01/06/2021
Onset Date: 01/06/2021
Rec V Date: 01/15/2021
Hospital:

Lab Data: Test Date: 202012; Test Name: Covid test; Result Unstructured Data: Test Result:Negative

Allergies:

Symptoms: Pain at injection site; Transient fever; Chills; This is a spontaneous report from a contactable consumer. An adult male patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date not reported), via an unspecified route of administration on 06Jan2021 at a single dose on left arm for COVID-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date not reported), via an unspecified route of administration on 17Dec2020 at a single dose on left arm for COVID-19 immunization. The patient experienced pain at injection site, transient fever, and chills on 06Jan2021. No treatment received for adverse events. The patient underwent lab tests and procedures which included COVID test result = Negative on Dec2020. The outcome of the events was recovering. The events were assessed as non-serious. It was unknown if patient received any other vaccines within 4 weeks prior to the COVID vaccine. List of any other medications the patient received within 2 weeks of vaccination was also unknown Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19 on Dec2020, result was negative. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0945916
Sex: F
Age:
State: TX

Vax Date: 01/06/2021
Onset Date: 01/07/2021
Rec V Date: 01/15/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Significant painful lymphadenopathy in the R axilla; This is a spontaneous report from a contactable physician. A 27-year-old female patient received the the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot:EL3248), intramuscularly in the right arm, on 06Jan2021 at a single dose for covid-19 immunization. The patient has no medical history. The patient has no known allergies. Concomitant medications included escitalopram oxalate (LEXAPRO), cetirizine hydrochloride (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) and OCP. The patient experienced significant painful lymphadenopathy in the right axilla on 07Jan2021 20:00 with outcome of not recovered. The outcome of the event was not recovered. The patient did not receive treatment for the event. The patient did not have Covid prior to vaccination. The patient has not been tested for Covid post-vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine.

Other Meds: LEXAPRO; ZYRTEC [CETIRIZINE HYDROCHLORIDE]

Current Illness:

ID: 0945917
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/15/2021
Hospital:

Lab Data: Test Name: Covid-19; Test Result: Positive

Allergies:

Symptoms: Caller received the first dose of covid 19 vaccine and tested positive for covid.; Caller received the first dose of covid 19 vaccine and tested positive for covid.; Caller received the first dose of covid 19 vaccine and tested positive for covid.; This is a spontaneous report from a Pfizer-sponsored program Pfizer First Connect. A contactable other health professional (patient) reported that a female (age: 22; unit: not reported) patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received the first dose of COVID 19 vaccine and tested positive for COVID on an unspecified date. She was under quarantine and wanted to know when and if she should get the second dose. Due date for second dose is 11Jan2021. The patient underwent lab tests and procedures which included Covid-19: positive on an unspecified date. The outcome of event was unknown. Information on the lot/ batch number has been requested.; Sender's Comments: The association between the event lack of effect (Covid-19 test positive) with BNT162b2 can not be completely excluded.

Other Meds:

Current Illness:

ID: 0945918
Sex: F
Age:
State:

Vax Date: 01/07/2021
Onset Date: 01/08/2021
Rec V Date: 01/15/2021
Hospital:

Lab Data: Test Date: 20210108; Test Name: Rapid PCR Test; Test Result: Positive

Allergies:

Symptoms: had her 1st dose of Covid vaccine yesterday and started experiencing all expected side effects today including lost of smell and taste/ Rapid PCR Test which came back positive; had her 1st dose of Covid vaccine yesterday and started experiencing all expected side effects today including lost of smell and taste/ Rapid PCR Test which came back positive; This is a spontaneous report from a contactable nurse (patient). A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date not provided), via an unspecified route of administration on 07Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient had her 1st dose of COVID vaccine yesterday, 07Jan2021 and started experiencing all expected side effects today (08Jan2021) including loss of smell and taste. She also had a Rapid PCR test done today which came back positive. She wanted to know if this could be a false positive result from the vaccine. The outcome of the events was unknown. Information on the lot/batch number has been requested.; Sender's Comments: Based on the current available information and the plausible drug-event temporal association, a possible contributory role of the suspect product BNT162B2 to the development of events Drug ineffective and COVID-19 cannot be totally excluded. The case will be reassessed if additional information becomes available.

Other Meds:

Current Illness:

ID: 0945919
Sex: M
Age:
State:

Vax Date: 01/06/2021
Onset Date: 01/01/2021
Rec V Date: 01/15/2021
Hospital:

Lab Data:

Allergies:

Symptoms: he "feels heated up, on the inside" from the waist up; This is a spontaneous report from a contactable consumer (spouse). An-82-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, batch/lot unknown), via an unspecified route of administration on 06Jan2021 at a single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. In Jan 2021, the patient experienced he "feels heated up, on the inside" from the waist up. The patient did not report fever. The outcome of the event was unknown. Information on lot number/batch number was requested.

Other Meds:

Current Illness:

ID: 0945920
Sex: F
Age:
State: FL

Vax Date: 12/19/2020
Onset Date: 12/19/2020
Rec V Date: 01/15/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Right arm pain; This is a spontaneous report from a contactable physician. A 44-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot: Eh9899), via an unspecified route of administration in the left arm on19Dec2020 10:30 at a single dose for covid-19 immunization. The patient has no relevant medical history. Patient has no allergies to medications, food, or other products. The patient's concomitant medications were not reported. On 19 December 2020, the patient experienced right arm pain. No treatment was given for the event. The outcome of the event was recovered. The vaccine was administered in the hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine and was not diagnosed with COVID-19 prior to vaccination. Patient has not been tested for COVID-19 since the vaccination. Information on Lot/Batch has been requested.

Other Meds:

Current Illness:

ID: 0945921
Sex: M
Age:
State: NV

Vax Date: 01/06/2021
Onset Date: 01/07/2021
Rec V Date: 01/15/2021
Hospital:

Lab Data: Test Date: 20201221; Test Name: nasal swab, L UMIRADX SARS-COV-2 AG test; Result Unstructured Data: Test Result:Negative

Allergies:

Symptoms: chills; tonsillitis/tonsils were inflamed; uvulitis/uvula were inflamed; body malaise; This is a spontaneous report from a contactable nurse (patient). A 48-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), lot number: EH9899, then intramuscular on left arm from 06Jan2021 08:15 to 06Jan2021 08:15 as SINGLE DOSE for COVID-19 immunisation. Medical history included eczema. Historical Vaccine includes: first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) on 16Dec2020 09:15. Concomitant medication included halobetasol propionate 0.05% ointment. On 07Jan2021, experienced body malaise (after 24 hours of receiving vaccine). On 08Jan2021, the patient experienced uvulitis, tonsillitis (after 48 hours of receiving the vaccine). The patient suddenly woke up from sleep feeling something was in his throat. Looked in the mirror and my uvula & tonsils were inflamed. On 08Jan2021, 08:00am, the patient experienced chills. No other symptoms accompanying the swelling of tonsils, uvula. The patient underwent nasal swab, L UMIRADX SARS-COV-2 AG test on 21Dec2020 with negative result. The outcome of the events was recovering at the time of the report. No treatment was given for the events.

Other Meds: HALOBETASOL PROPIONATE

Current Illness:

ID: 0945922
Sex: F
Age:
State: AL

Vax Date: 01/06/2021
Onset Date: 01/06/2021
Rec V Date: 01/15/2021
Hospital:

Lab Data: Test Date: 20210106; Test Name: fever; Result Unstructured Data: Test Result:104; Comments: 19:00; Test Date: 20210108; Test Name: Nasal Swab; Result Unstructured Data: Test Result:pending results; Comments: Send off; Test Date: 20210108; Test Name: Rapid test; Test Result: Negative

Allergies:

Symptoms: Fever max of 104; Body aches; Fatigue; This is a spontaneous report from a contactable nurse (patient). A 37-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration; first dose (lot EH9899) on 16Dec2020 19:00 (07:00 P.M.) and then the second dose (lot EJ1685) on 06Jan2021 08:00 A.M.; both at a single dose on the left arm as COVID vaccine. Medical history included hypertension; known allergies to sulfa, milk, and iv contrast. Concomitant medications were not reported. The patient had known allergies to doxycycline, morphine, oxycodone hydrochloride/oxycodone terephthalate/paracetamol (TYLOX), and ceftriaxone sodium (ROCEPHIN). The patient experienced fever max of 104 with Motrin and Tylenol 2 days, body aches, fatigue, all on 06Jan2021 19:00 that were assessed as non-serious in which did not result in death, not life threatening, did not caused/prolonged hospitalization, not disabling/incapacitating, did not cause congenital anomaly/birth defect. The events resulted to a doctor or other healthcare professional office/clinic visit. The patient was not pregnant at the time of vaccination. She was vaccinated in a hospital (facility where the most recent COVID-19 vaccine was administered). She did not receive other vaccines within four weeks prior to the COVID vaccine and did not receive any other medications within 2 weeks of vaccination. She was not diagnosed with COVID-19 prior to vaccination. She had been tested for COVID-19 since the vaccination in which lab data included nasal swab Send off pending results and rapid test was negative, both on 08Jan2021. Therapeutic measures were taken as a result of fever max of 104 while treatment was not received for the rest of events. The outcome of the events was recovering.

Other Meds:

Current Illness:

ID: 0945923
Sex: F
Age:
State: NM

Vax Date: 01/06/2021
Onset Date: 01/06/2021
Rec V Date: 01/15/2021
Hospital:

Lab Data:

Allergies:

Symptoms: dry, tight, scratchy throat; dry, tight, scratchy throat; dry, tight, scratchy throat; This is a spontaneous report from a contactable pharmacist. A 38-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot EL0142) intramuscular on 06Jan2021 18:15 (06:15 PM) at a single dose for COVID vaccine. Medical history included anxiety; known allergies to latex, penicillin, wheat, gluten. Concomitant medications were not reported. It was unknown if the patient was pregnant at the time of vaccination. It was unknown if the patient received other vaccines within four weeks prior to the COVID vaccine and there were no documented other medications within 2 weeks of vaccination. The patient was vaccinated in a hospital (facility where the most recent COVID-19 vaccine was administered). On 06Jan2021 18:15, the patient complained of dry, tight, scratchy throat after receiving vaccine; assessed as non-serious in which did not result in death, not life threatening, did not caused/prolonged hospitalization, not disabling/incapacitating, did not cause congenital anomaly/birth defect. The patient was monitored and instructed to monitor at home. Treatment was not received for the events. It was unknown if she was diagnosed with COVID-19 prior to vaccination and also unknown if she had COVID-19 tested post vaccination. The outcome of the events was unknown.

Other Meds:

Current Illness:

ID: 0945924
Sex: F
Age:
State: GA

Vax Date: 01/07/2021
Onset Date: 01/07/2021
Rec V Date: 01/15/2021
Hospital:

Lab Data:

Allergies:

Symptoms: body aches; Nausea; vomiting; fatigue; headache; lymphadenopathy; This is a spontaneous report from a contactable physician (patient). A 29-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot/batch number: EL0142), via an unspecified route of administration on the left arm on 07Jan2021 08:00 at SINGLE DOSE for COVID-19 immunization at the hospital. Medical history included ankylosing spondylitis, migraine, anxiety, and insomnia. Concomitant medications included fluvoxamine (FLUVOXAMINE), and adalimumab (ADALIMUMAB). The patient previously received the first dose of PFIZER-BIONTECH COVID-19 VACCINE (lot/batch number: EJ1685) via unknown route of administration on the left arm on 17Dec2020 17:30 at a single dose for COVID-19 immunization. On 07Jan2021 18:00, the patient experienced Nausea, vomiting, fatigue, headache, lymphadenopathy, and body aches. Prior to vaccination the patient was not diagnosed with COVID-19 and since the vaccination, has not been tested for COVID-19. The patient did not receive any treatment for the events. The patient recovered from the events in Jan2021. No follow-up attempts are possible. No further information is expected.

Other Meds: ;

Current Illness:

ID: 0945925
Sex: F
Age:
State: PA

Vax Date: 01/06/2021
Onset Date: 01/06/2021
Rec V Date: 01/15/2021
Hospital:

Lab Data: Test Date: 20210108; Test Name: Nasal Swab; Result Unstructured Data: Test Result:pending

Allergies:

Symptoms: sore throat; Fatigue; fever; injection site soreness; This is a spontaneous report from a contactable other HCP (patient). A 38-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) (lot number/expiration date: unknown), via uknown route of administration, on 06Jan2021 at 11:15 AM (at the age of 38 years old) as a single dose in the right arm for COVID-19 immunization at hospital facility. Relevant medical history included anxiety and depression. The patient has known allergies to sulfa drugs. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not provided. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 06Jan2021 evening, the patient experienced injection site soreness at 6:30 PM, fatigue and fever at 7:30 PM. Fatigue and fever were gone by morning. Injection site soreness faded every day. On 08Jan2021, the patient experienced sore throat. No treatment was received for the events injection site soreness, fatigue, fever and sore throat. The outcome of the events injection site soreness, fatigue, fever and sore throat was recovering. The patient was not pregnant at time of vaccination. Since the vaccination, the patient had been tested for COVID-19 via COVID test Nasal Swab on 08Jan2021 with pending result. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 0945926
Sex: F
Age:
State: SC

Vax Date: 01/07/2021
Onset Date: 01/08/2021
Rec V Date: 01/15/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Chills; body ache; headache; insomnia; This is a spontaneous report from a contactable healthcare professional (patient). A 53-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date: unknown), intramuscular on the right arm on 07Jan2021 16:00 at a single dose for COVID-19 immunization. Medical history included depression. Patient was not pregnant. Concomitant medication included duloxetine hydrochloride (CYMBALTA). The patient experienced chills, body ache, headache, insomnia on 08Jan2021 02:00. Outcome of the events was not recovered. No treatment was given for the adverse events. The reporter assessed the events as non-serious. Patient was not diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. Information of lot/batch number has been requested.

Other Meds: CYMBALTA.

Current Illness:

ID: 0945927
Sex: F
Age:
State: IN

Vax Date: 01/06/2021
Onset Date: 01/07/2021
Rec V Date: 01/15/2021
Hospital:

Lab Data: Test Name: Body Temp; Result Unstructured Data: Test Result:98.5 Fahrenheit

Allergies:

Symptoms: chills; This is a spontaneous report from a contactable healthcare professional, the patient. A 21-year old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), Lot number: EL0142, intramuscularly in the left deltoid on 06Jan2021 at 08:00 (at the age of 21-years-old) at 0.3 "mg" as a single dose for COVID-19 immunization. Medical history included birth control use and obesity. Concomitant medications included ongoing ethinylestradiol/norgestimate (SPRINTEC) tablet for birth control. The patient did not receive any vaccinations within 4 weeks prior to the vaccination. The patient previously took methylphenidate hydrochloride (CONCERTA) 27 mg and experienced lack of appetite and was still having sleepiness (insomnia she guessed) and therefore was dropped to 18 mg and still had side effects; as well as guanfacine. On 07Jan2021 at 21:00, the patient experienced chills. She thought it was just her mom's house being cold, but she had a little bit of a chill all day today (08Jan2021). She didn't have a fever. The last time she took her temperature it was 98.5 degrees Fahrenheit, which was normal for her. The caller stated she did have a slower metabolism when it came to medication. She didn't know 100% if she hadn't been exposed to COVID, as she worked in healthcare and worked last on Monday. The event, chills, did not prompt an emergency room or physician office visit. The caller was worried if this was a normal side effect of the vaccine or if she was getting sick with COVID. She would go through with the COVID test she had scheduled for "tomorrow morning" as she was still experiencing side effects. The chills stayed the same or were a little worse. The clinical outcome of chills was not resolved.

Other Meds: SPRINTEC

Current Illness:

ID: 0945928
Sex: F
Age:
State: OH

Vax Date: 12/17/2020
Onset Date:
Rec V Date: 01/15/2021
Hospital:

Lab Data:

Allergies:

Symptoms: With first shot just body aches; This is a spontaneous report from a contactable nurse (patient). A 33-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EH9899), intramuscular in right arm on 17Dec2020 at a single dose for covid-19 immunization. Medical history included depression. Patient was not pregnant at the time of vaccination. Concomitant medication included escitalopram oxalate (LEXAPRO). Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was not diagnosed with COVID-19. The patient experienced with first shot just body aches on an unspecified date. No treatment was received for the adverse event. Since the vaccination, the patient has not been tested for COVID-19. The outcome of the event was recovered.

Other Meds: LEXAPRO

Current Illness:

ID: 0945929
Sex: F
Age:
State: NM

Vax Date: 01/07/2021
Onset Date: 01/07/2021
Rec V Date: 01/15/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Patient complained of left arm pain radiating to jaw and temples radiating to neck pain after injection; Patient complained of left arm pain radiating to jaw and temples radiating to neck pain after injection; Patient complained of left arm pain radiating to jaw and temples radiating to neck pain after injection; Patient complained of left arm pain radiating to jaw and temples radiating to neck pain after injection; This is a spontaneous report form a contactable physician. A 45-year-old female patient received the first dose of bnt162b2 (BNT162B2, lot number: EL0142, expiry date: not reported) intramuscular, on 07Jan2021 07:30 AM on Arm Left at a single dose for COVID-19 immunization. COVID-19 vaccine was administered at a hospital. Medical history was not reported. It was unknown if patient was pregnant at the time of vaccination. She did not receive any other vaccines within 4 weeks prior to the COVID vaccine. It was unknown if the patient was diagnosed with COVID-19 prior to vaccination. Concomitant medications were not reported. On 08Jan2021 07:30 AM, the patient complained of left arm pain radiating to jaw and temples radiating to neck pain after injection. Treatment was not received for the adverse events. Outcome of the events was unknown.

Other Meds:

Current Illness:

ID: 0945930
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/15/2021
Hospital:

Lab Data:

Allergies:

Symptoms: right sided facial tingling after receiving his first vaccination/ numbness and tingling lasted approx. 3 days; right sided facial tingling after receiving his first vaccination/ numbness and tingling lasted approx. 3 days; This is a spontaneous report from a non-contactable other healthcare professional. A 38-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot/batch number not reported), via an unspecified route of administration in right deltoid muscle on an unspecified date at a single dose for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, patient was seen at the COVID Vaccine Clinic today for his second dose of the COVID 19 vaccination (Lot number: EK9231). He denied any history of previous adverse reactions to other vaccines but does note he had tingling to the right side of his face after his first dose that lasted 3 days. He was given the Pfizer vaccination in the right deltoid muscle. During his 15 minute waiting period after the injection, the patient began to experience tingling to right side of face. Patient states he had right sided facial tingling after receiving his first vaccination but was not evaluated in the medical bay. He states the numbness and tingling lasted approx. 3 days. Denied weakness in right sided facial muscles at that time. Stable to go home and follow up with PCP. The outcome of the events was recovered. No follow-up attempts are possible; information regarding lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 0945931
Sex: F
Age:
State: CA

Vax Date: 12/20/2020
Onset Date: 12/21/2020
Rec V Date: 01/15/2021
Hospital:

Lab Data:

Allergies:

Symptoms: muscle soreness at greater injection site; This is a spontaneous report from a contactable other healthcare professional. A 59-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number=EJ1685), intramuscular in left arm on 20Dec2020 16:00 at a single dose for Covid-19 immunization. Medical history included diabetes and hypertension. Patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was not diagnosed with COVID-19. Patient has no allergies to medications, food or other products. The patient's concomitant medications included prescribed medication (unspecified). The patient experienced muscle soreness at greater injection site on 21Dec2020 at 06:00 AM. No treatment was received for the adverse event. Since the vaccination, the patient has not been tested for COVID-19. The outcome of the event was recovered.

Other Meds:

Current Illness:

ID: 0945932
Sex: F
Age:
State:

Vax Date: 12/31/2020
Onset Date: 01/05/2021
Rec V Date: 01/15/2021
Hospital:

Lab Data:

Allergies:

Symptoms: A series of several bumps have turned into sores inside of her mouth/ located on the right side of mouth inside the gum of her back bottom teeth and now turning into clusters of blisters; A series of several bumps have turned into sores inside of her mouth/ located on the right side of mouth inside the gum of her back bottom teeth and now turning into clusters of blisters; This is a spontaneous report from a contactable other healthcare professional (patient). A 27-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number: EJ1686), via an unspecified route of administration in left arm on 31Dec2020 at 02:45 PM at a single dose for Covid-19 immunization. Medical history included Covid-19. Prior to vaccination, patient was diagnosed with COVID-19. Patient was not pregnant at the time of vaccination. Patient has no allergies to medications, food, or other products. The patient's concomitant medications were not reported. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 05Jan2021 at 05:45 PM, the patient experienced series of several bumps have turned into sores inside of her mouth. They are located on the right side of her mouth inside the gum of her back bottom teeth. They are now turning into clusters of blisters. It was unknown whether treatment was received for the adverse events. Since the vaccination, patient has not been tested for COVID-19. The outcome of the events was not recovered.

Other Meds:

Current Illness:

ID: 0945933
Sex: F
Age:
State: CA

Vax Date: 12/28/2020
Onset Date: 01/04/2021
Rec V Date: 01/15/2021
Hospital:

Lab Data: Test Date: 20210104; Test Name: temperature; Result Unstructured Data: Test Result:100.4 Fahrenheit; Test Date: 20210107; Test Name: temperature; Result Unstructured Data: Test Result:101.4 Fahrenheit; Test Date: 20210107; Test Name: Rapid Nasal Pharyngeal; Result Unstructured Data: Test Result:unknown results

Allergies:

Symptoms: mid-grade fever with a temperature of 100.4 degrees F. The temperature peaked 101.4 degrees F last night.; Chills; This is a spontaneous report from a contactable consumer (patient). A 63-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EH9899), via an unspecified route of administration in the left arm on 28Dec2020 11:45 at a single dose for COVID-19 immunization. The patient's medical history included asthma, sulfur/sulfameds allergies, and iodine dye allergies. The patient was not pregnant at the time of vaccination. Concomitant medications included estradiol (ESTROGEN), progesterone, colecalciferol (VITAMIN D), allergy shots, and multivitamin. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 04Jan2021 18:00, the patient experienced chills and were continuing today. She was experiencing a mid-grade fever with a temperature of 100.4 degrees Fahrenheit on 04Jan2021. The temperature peaked 101.4 degrees Fahrenheit last night (07Jan2021). The adverse events resulted in doctor or other healthcare professional office/clinic visit. The patient underwent lab tests and procedures which included rapid nasal pharyngeal COVID test which showed unknown results on 07Jan2021. Outcome of the events was not recovered. The events were considered non-serious by the reporter.

Other Meds: ESTROGEN; ; VITAMIN D [COLECALCIFEROL]

Current Illness:

ID: 0945934
Sex: M
Age:
State:

Vax Date: 01/01/2021
Onset Date: 01/01/2021
Rec V Date: 01/15/2021
Hospital:

Lab Data: Test Date: 202101; Test Name: temperature; Result Unstructured Data: Test Result:104

Allergies:

Symptoms: It felt like a viral meningitis; arm soreness; feel some tension; migraine headache; body started shaking; chills/Rigors; temperature 104; I had sensitivity that I never had; headache; photophobia; Sinophobia; paresthesia/tingling sensation along my upper extremity; I felt like I was freezing; I didn't feel comfortable; vertigo; nausea; hard time to focus; This is a spontaneous report from a contactable other health professional (patient himself). A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in Jan2021 at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. He didn't have any allergies. He was in good health, no underlying issue. He never had a surgery. In Jan2021, patient got the vaccine last night around. It started with arm soreness. Around 10:00 am he started to feel some tension, migraine headache. Around 11:00 he felt his body started shaking. He had chills, rigors and temperature 104. For 5-6 hours he had sensitivity that he never had. Patient had a headache, photophobia, sinophobia, paresthesia and tingling sensation along his upper extremity. he felt like he was freezing. He didn't feel comfortable. It resolved afterwards, he felt no weakness, no facial paralysis. It felt like a viral meningitis. He also had vertigo, nausea and hard time to focus. Outcome of events were unknown. Information about lot/batch number has been requested.; Sender's Comments: Based on the temporal relationship, the association between the event viral meningitis with BNT162b2 can not be fully excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.

Other Meds:

Current Illness:

ID: 0945935
Sex: F
Age:
State: NM

Vax Date: 01/06/2021
Onset Date: 01/06/2021
Rec V Date: 01/15/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Anxiety; Headache; Seeing stars; Chest tightness; Hand tremor; SOB; This is a spontaneous report from a contactable pharmacist. A 40-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EL1284; Expiration date was not reported), intramuscularly on the left arm on 06Jan2021 (10:15) at a single dose for COVID-19 immunization at the hospital. Medical history included migraines; heart murmur with surgery; grand mal seizure that has resolved; and contrast dye allergy. Concomitant medications included sumatriptan and norethindrone [norethisterone]. The patient previously took phenytoin, iodine, terconazole, tramadol and cetirizine; and had allergies with these medications. On 06Jan2021 (10:15), the patient was seeing stars; had chest tightness; hand tremor; and shortness of breath (SOB). The patient was referred to the Urgent Care Clinic due to these events. On 06Jan2021 (12:30), at the Urgent Clare Clinic, the patient had anxiety and headache. The patient had received acetaminophen, diphenhydramine, ibuprofen and water as treatment for the events, 'seeing stars', 'chest tightness', 'hand tremor' and 'shortness of breath'; and was provided with education on managing anxiety. The outcome of the events was recovered in Jan2021 for 'seeing stars', 'chest tightness', 'hand tremor' and 'shortness of breath'; and was unknown for 'headache' and 'anxiety'. The patient did not have COVID-19 prior to vaccination, and was not tested post-vaccination.

Other Meds: ; NORETHINDRONE [NORETHISTERONE]

Current Illness:

ID: 0945936
Sex: M
Age:
State: OR

Vax Date: 01/08/2021
Onset Date: 01/08/2021
Rec V Date: 01/15/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Facial tingling, itching and redness; Facial tingling, itching and redness; Facial tingling, itching and redness; This is a spontaneous report from a contactable nurse (patient). A 64-year-old male patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiration date were not reported), intramuscular in the right arm on 08Jan2021 10:00 at a single dose for COVID-19 immunization. The patient's medical history included mild adrenal insufficiency. Concomitant medication included hydrocortisone to 06Jan2021. The patient previously took lidocaine and experienced allergies to lidocaine and first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) for COVID-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination and had not been tested for COVID-19 since the vaccination. The patient experienced facial tingling, itching and redness on 08Jan2021 10:45. Therapeutic measures were taken as a result of facial tingling, itching and redness and included treatment with self administered chlorpheniramine 12 mg. Outcome of the events was recovered on Jan2021. The events were considered non-serious by the reporter. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0945937
Sex: M
Age:
State: FL

Vax Date: 01/06/2021
Onset Date: 01/06/2021
Rec V Date: 01/15/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Fever 101; Headaches; Bodyaches; Fatigue; This is a spontaneous report from a contactable physician. An adult male patient started to receive bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number Ek4231), via an unspecified route of administration from 06Jan2021 09:00 to 06Jan2021 09:00 at a single dose for an unspecified indication. The patient's medical history and concomitant medications were not reported. The patient took the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE on 16Dec2020. It was reported that the patient experienced Fever 101, Headaches, Bodyaches and Fatigue on 06Jan2021. The patient took Tylenol as treatment. The outcome of the events was recovered on an unspecified date in Jan2021.

Other Meds:

Current Illness:

ID: 0945938
Sex: F
Age:
State: NJ

Vax Date: 01/05/2021
Onset Date: 01/05/2021
Rec V Date: 01/15/2021
Hospital:

Lab Data: Test Date: 20210106; Test Name: Body temperature; Result Unstructured Data: Test Result:101.7; Comments: took her temperature orally and ran a fever of 101.7 that evening

Allergies:

Symptoms: nausea; headache; palpitation; chills; Fatigued; took my temperature orally and ran a fever of 101.7; first dose of bnt162b2 on 18Dec2020 at 12:30 PM, second dose on 05Jan2021 at 16:00; first dose of bnt162b2 on 18Dec2020 at 12:30 PM, second dose on 05Jan2021 at 16:00; soreness/body aches; initially had injection site pain; This is a spontaneous report from a contactable nurse (patient). A 24-year-old female patient (not pregnant) received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EL0142), intramuscularly on 05Jan2021 at 16:00 on Left arm at single dose for COVID-19 immunization in hospital. Medical history included Atopic Dermatitis and had Known allergies with Nickel, Cobalt, Dust Mites, Grass pollen. Prior to vaccination, patient was not diagnosed with COVID-19. The patient's concomitant medications reported as no. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EJ1685) intramuscularly on 18Dec2020 at 12:30 PM on Left arm at single dose for COVID-19 immunization at age of 24-year-old. The patient initially had injection site pain and soreness on 05Jan2021. On 06Jan2021 she went to work and was fatigued with body aches, nausea, headache, palpitation and chills during her shift at 07:00 AM. She came home and took her temperature orally and ran a fever of 101.7 that evening on 06Jan2021. She took acetaminophen and managed to lower the fever. As of today 08Jan2021, current complaints were fatigue, body aches, and a headache. Since the vaccination, patient had not been tested for COVID-19. Therapeutic measures were taken as a result of event fever included acetaminophen. The outcome of the events fatigue, body aches and headache was not recovered; outcome of event Fever was recovered on 08Jan2021; outcome of the other events was unknown. The report was reported as non-serious, with seriousness criteria-Results in death: No; Life threatening: No; Caused/prolonged hospitalization: No; Disabling/Incapacitating: No; Congenital anomaly/birth defect: No.

Other Meds:

Current Illness:

ID: 0945939
Sex: F
Age:
State: CA

Vax Date: 01/06/2021
Onset Date: 01/07/2021
Rec V Date: 01/15/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Redness and swelling on injection site; Redness and swelling on injection site; This is a spontaneous report from a non-contactable nurse (patient). A 46-year-old female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EL3246), intramuscular in the left arm on 06Jan2021 15:30 at a single dose for COVID-19 immunization. There were no medical history. The patient was not pregnant at the time of vaccination. The patient had no known allergies to medications, food, or other products. Concomitant medication included colecalciferol (VITAMIN D) and Estro-Aid. The patient previously took the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: Ek5730), intramuscular in the right arm on 17Dec2020 at the age of 46-year-old for COVID-19 immunization and experienced mild cough. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination and had not been tested for COVID-19 since the vaccination. On 07Jan2021 20:00, the patient experienced redness and swelling on injection site. No treatment was received for the adverse events. Outcome of the events was recovering. The events were considered non-serious by the reporter. No follow-up attempts are possible. No further information is expected.

Other Meds: VITAMIN D [COLECALCIFEROL]

Current Illness:

ID: 0945940
Sex: F
Age:
State: OK

Vax Date: 01/08/2021
Onset Date: 01/08/2021
Rec V Date: 01/15/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Nausea; dizziness; fever; This is a spontaneous report from a contactable other healthcare professional (patient). A 41-year-old female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: El1283), via an unspecified route of administration in the left arm on 08Jan2021 08:00 at a single dose for COVID-19 immunization. The patient's medical history included migraine and seasonal allergies. The patient was not pregnant at the time of vaccination. The patient have no known allergies to medications, food, or other products. Concomitant medications included melatonin and levocetirizine dihydrochloride (XYZAL). The patient previously took the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: Eh9899), intramuscular in the left arm on 18Dec2020 at the age of 41-year-old for COVID-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination and had not been tested for COVID-19 since the vaccination. On 08Jan2021 09:30, the patient experienced nausea, dizziness, fever. No treatment was received for the adverse events. Outcome of the events was not recovered. The events were considered non-serious by the reporter.

Other Meds: ; XYZAL

Current Illness:

ID: 0945941
Sex: M
Age:
State: WA

Vax Date: 01/06/2021
Onset Date: 01/07/2021
Rec V Date: 01/15/2021
Hospital:

Lab Data:

Allergies:

Symptoms: injection site pain; tiredness; headache; muscle pain; chills; joint pain; fever; This is a spontaneous report from a contactable Other Health Professional(patient). A 27 years old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot EK9231) via Intramuscular on 06Jan2021 18:00 at single dose in the arm left for COVID-19 immunisation. Medical history was none. Concomitant medications were not reported. On 07Jan2021 04:00 PM, the patient experienced injection site pain, tiredness, headache, muscle pain, chills, joint pain and fever. The patient did not receive any treatment. Outcome of events was recovering.

Other Meds:

Current Illness:

ID: 0945942
Sex: F
Age:
State:

Vax Date: 01/11/2021
Onset Date: 01/01/2021
Rec V Date: 01/15/2021
Hospital:

Lab Data:

Allergies:

Symptoms: I have latent TB and am diagnosed with herpes 1 and 2; I have latent TB and am diagnosed with herpes 1 and 2; This is a spontaneous report from a contactable other health professional. A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 11Jan2021 at single dose for covid-19 immunization. Patient had the first dose of the vaccine on 11Jan2021 and she/he had pre-existing conditions. A long time ago, she/he had 2 tachycardia episodes and was sensitive to epinephrine. Patient had latent TB and was diagnosed with herpes 1 and 2 in Jan2021. Outcome of events were unknown. Information about lot/batch number has been requested.; Sender's Comments: The association between the events "latent PTB and Herpes 1 and 2" with BNT162b2 can not be completely excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.

Other Meds:

Current Illness:

ID: 0945943
Sex: F
Age:
State: MA

Vax Date: 01/07/2021
Onset Date: 01/08/2021
Rec V Date: 01/15/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Flu-like symptoms; lethargy; athralgias; fatigue; This is a spontaneous report received from a contactable consumer. A 66-year-old female patient received her second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date not reported), via an unspecified route of administration in left arm, on 07Jan2021 08:00, at single dose, for COVID-19 immunization, in the hospital. Medical history included Meniere's disease and penicillin allergy. The patient was not pregnant at the time of vaccination. The patient had no other medications in two weeks. Historical vaccine included the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date not reported), via an unspecified route of administration in left arm, on 17Dec2020, for COVID-19 immunization. The patient experienced flu-like symptoms, lethargy, athralgias and fatigue on 08Jan2021 at 21:45. The patient did not receive treatment for the events. Prior to vaccination, the patient was not diagnosed with COVID-19. Since vaccination, the patient has not been tested for COVID-19. The outcome of the events was not recovered. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0945944
Sex: F
Age:
State:

Vax Date: 01/06/2021
Onset Date: 01/06/2021
Rec V Date: 01/15/2021
Hospital:

Lab Data:

Allergies:

Symptoms: significant muscle aches; chills; joint pain; Neck pain with headache that night; Neck pain with headache that night; This is a spontaneous report from a non-contactable healthcare professional. A 45-year-old non-pregnant female patient received her first dose of bnt162b2 (BNT162B2 reported as COVID 19 vaccine; unknown lot number and expiration date), intramuscular right arm on 06Jan2021 14:00 [02:00 PM] at a single dose for covid-19 vaccination. Medical history included breast cancer and had covid-19 prior vaccination. The patient has no known allergies. Concomitant medication included tamoxifen (TAMOXIFEN). The patient has not received any other vaccines within 4 weeks prior to the COVID vaccine. The patient received her most recent COVID-19 vaccine in a hospital. The patient experienced neck pain with headache that night (06Jan2021 22:00 [10:00 PM]) then next day (07Jan2020), significant muscle aches and chills with joint pain for another day and a half. The events were considered as non-serious. It was unknown if treatment was received. The patient was not diagnosed with COVID-19 prior to vaccination and has not been tested for COVID-19 since the vaccination. The outcome of the events was recovering. No follow-up attempts are possible; Information about Lot/Batch could not be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 0945945
Sex: F
Age:
State: TX

Vax Date: 12/18/2020
Onset Date: 12/18/2020
Rec V Date: 01/15/2021
Hospital:

Lab Data: Test Date: 20201218; Test Name: body temperature; Result Unstructured Data: Test Result:T-Max of 100.9; Test Date: 20210104; Test Name: Nasal Swab; Test Result: Negative

Allergies:

Symptoms: Fever (T-Max was 100.9); body aches; fatigue; This is a spontaneous report from a contactable nurse (patient). A 37-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot number: EK5730), via an unspecified route of administration in the right arm, on 18Dec2020 at 10:30 (at the age of 37-years-old) at a single dose for COVID-19 immunization. Medical history included COVID-19 (prior to vaccination). The patient was not pregnant at the time of vaccination. The patient did not receive any other mediations within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient experienced fever (temperature maximum (T-Max) was 100.9), body aches, and fatigue on 18Dec2020 at 13:30. The events were reported as non-serious. The patient underwent lab tests and procedures, which included body temperature: T-Max of 100.9 on 18Dec2020 and nasal swab: negative on 04Jan2021. The patient did not receive any treatment for the events. The clinical outcome of fever (T-Max was 100.9), body aches, and fatigue was recovered on 19Dec2020 at 22:30.

Other Meds:

Current Illness:

ID: 0945946
Sex: F
Age:
State: CA

Vax Date: 12/17/2020
Onset Date: 12/23/2020
Rec V Date: 01/15/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Mild cough after 1 week of vaccine; This is a spontaneous report from a non-contactable nurse. A 46-year-old female patient started to receive BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK5730) intramuscular (anatomical location: arm right) from 17Dec2020 07:45 to 17Dec2020 07:45, single dose for covid-19 immunisation. Medical history was reported as none. Concomitant medication included ergocalciferol (VIT D). On 23Dec2020 at 08:00, The patient experienced mild cough after 1 week of vaccine. The patient did not received any treatment for the event. Outcome of the event was recovering. No follow up attempts are possible. No further information is expected.

Other Meds: VIT D

Current Illness:

ID: 0945947
Sex: F
Age:
State:

Vax Date: 01/04/2021
Onset Date: 01/04/2021
Rec V Date: 01/15/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Soreness at injection sight; This is a spontaneous report from a contactable consumer. A 49-year-old female patient started to receive BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: 40113/ej1686), via an unspecified route of administration (anatomical location: left arm) from 04Jan2021 14:30 to 04Jan2021 14:30 at SINGLE DOSE for an COVID-19 immunisation. Medical history included diabetes, asthma and overweight. The patient's concomitant medications were not reported. On 04Jan2021, the patient experienced soreness at injection sight. Outcome of the event was unknown.

Other Meds:

Current Illness:

ID: 0945948
Sex: F
Age:
State: KY

Vax Date: 01/08/2021
Onset Date: 01/08/2021
Rec V Date: 01/15/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Headache, pain at injection site, nasal congestion, nasal pain.; Headache, pain at injection site, nasal congestion, nasal pain.; Headache, pain at injection site, nasal congestion, nasal pain.; Headache, pain at injection site, nasal congestion, nasal pain.; This is a spontaneous report from a contactable other health care professional. A 45-year-old female received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), first dose (lot number: EH9899); via an unspecified route of administration on 17Dec2020 14:00 at single dose at arm left; second dose (lot number: EK9231) via an unspecified route of administration on 08Jan2021 00:45 at SINGLE DOSE for COVID-19 immunization. Medical history included asthma, chronic back pain, Allergies to medications, food, or other products: Avocado. Concomitant medications included fexofenadine hydrochloride (ALLEGRA), celecoxib (CELEBREX), pregabalin (LYRICA), triamcinolone acetonide (NASACORT), omeprazole. On 08Jan2021 09:00, the patient experienced Headache, pain at injection site, nasal congestion, nasal pain. The events were assessed as non-serious. There was no treatment received for the events. The outcome of the events was recovering.

Other Meds: ALLEGRA; CELEBREX; LYRICA; NASACORT;

Current Illness:

ID: 0945949
Sex: F
Age:
State: MA

Vax Date: 01/08/2021
Onset Date: 01/08/2021
Rec V Date: 01/15/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Glands in throat swelling after eating, possibly of new food that she ate. However with the throat swelling she also had tongue itchiness; Glands in throat swelling after eating, possibly of new food that she ate. However with the throat swelling she also had tongue itchiness; headache; This is a spontaneous report from a contactable nurse. A 25-year-old female patient started to receive BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: unknown), via an unspecified route of administration (anatomical location: arm left) from 08Jan2021 12:30 to 08Jan2021 12:30 at SINGLE DOSE for COVID-19 immunisation. Medical history included OCD, anxiety, depression and Known Allergies: Mushrooms. Concomitant medication included fluvoxamine maleate (LUVOX), trazodone, clonidine, diphenhydramine hydrochloride (BENADRYL) and melatonin. The patient previously took cogentin and experienced known allergies. The patient had first vaccination with bnt162b2 from 21Dec2020 to 21Dec2020 for covid-19 immunisation. On 08Jan2021 at 16:00, the patient stated that she had glands in throat swelling after eating, possibly of new food that she ate. however with the throat swelling she also had tongue itchiness and the patient had headache. Therapeutic measures were taken as a result of tongue pruritus and pharyngeal swelling included Benadryl. The patient did not received any treatment for the event headache. Outcome of the events tongue pruritus and pharyngeal swelling was recovered on an unspecified date in Jan2021 while outcome of the event headache was unknown. Information Requested on Lot/ Batch number.

Other Meds: LUVOX; ; ; BENADRYL;

Current Illness:

ID: 0945950
Sex: F
Age:
State: NJ

Vax Date: 01/04/2021
Onset Date: 01/08/2021
Rec V Date: 01/15/2021
Hospital:

Lab Data: Test Name: Rapid test; Test Result: Negative ; Test Name: Rapid test; Test Result: Negative

Allergies:

Symptoms: Chills; Fever; Cough; Ear pain; This is a spontaneous report from a contactable consumer (medical assistant and patient herself). A 34-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number and Expiration Date were not reported), via an unspecified route of administration, on 04Jan2021, at a single dose, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received BNT162B2 vaccine last Monday (04Jan2021). However, the patient started having symptoms of chills, fever, cough, and ear pain today (08Jan2021). The patient already did the rapid test twice, but tested negative on both tests. The patient wanted to know if it is normal to experience these symptoms even if it has been 5 days already since she received the vaccine. The outcome of the events was unknown. Information about lot number and expiration date for the suspect product will be requested in follow-up attempts.

Other Meds:

Current Illness:

ID: 0945951
Sex: F
Age:
State: WI

Vax Date: 01/07/2021
Onset Date: 01/08/2021
Rec V Date: 01/15/2021
Hospital:

Lab Data:

Allergies:

Symptoms: chills; extremely painful injection site and was unable to lift affected arm over head easily; extremely painful injection site and was unable to lift affected arm over head easily.; This is a spontaneous report from a contactable nurse. A 64-year-old female patient started to receive BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK9231), intramuscular (anatomical location: arm left) from 07Jan2021 18:00 to 07Jan2021 18:00 at SINGLE DOSE for an unspecified indication. Medical history included known allergies: PCN. There were no concomitant medications. On 08Jan2021 at 12:00, The patient experienced extremely painful injection site and was unable to lift affected arm over head easily and then chills. The patient did not received any treatment for the events. Outcome of the events was recovering.

Other Meds:

Current Illness:

ID: 0945952
Sex: F
Age:
State: MI

Vax Date: 01/07/2021
Onset Date: 01/08/2021
Rec V Date: 01/15/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Painful , very enlarged lymph nodes in right Axilla, Collarbone area, right side of neck and right breast. Extremely painful and swollen. Started approx 26 hours after injection - came on suddenly; Painful , very enlarged lymph nodes in right Axilla, Collarbone area, right side of neck and right breast. Extremely painful and swollen. Started approx 26 hours after injection - came on suddenly; This is a spontaneous report from a contactable nurse. A 41-year-old female patient started to receive BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EJ1685), via an unspecified route of administration (anatomical location: arm right) from 07Jan2021 14:00 to 07Jan2021 14:00 at SINGLE DOSE for COVID-19 immunisation. Medical history included hypertension, pancreatitis, If-covid-prior-vaccination: Yes and allergies sulfa meds. Concomitant medication included paracetamol (TYLENOL) and metoprolol. The patient previously took codeine for allergies. The patient had first vaccine of BNT162B2 from 18Dec2020 to 18Dec2020 for COVID-19 immunization. On 08Jan2021 at 16:30, the patient had painful, very enlarged lymph nodes in right axilla, collarbone area, right side of neck and right breast. extremely painful and swollen. Started approx 26 hours after injection - came on suddenly. Outcome of the events was not recovered.

Other Meds: TYLENOL;

Current Illness:

ID: 0945953
Sex: F
Age:
State: OR

Vax Date: 01/05/2021
Onset Date: 01/05/2021
Rec V Date: 01/15/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Insomnia; Racing thoughts; This is a spontaneous report from a contactable consumer (patient herself). A 43-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection; batch/lot number and expiration date were unknown), via an unspecified route of administration on the left arm on 05Jan2021 at 13:00 at a single dose for COVID-19 immunization administered at the hospital. Relevant medical history included chronic migraines, high blood pressure, and known allergies to tree nuts. The patient's concomitant medications were not reported. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 05Jan2021 at 16:00, the patient experienced insomnia and racing thoughts, which were assessed as non-serious. The patient did not receive any treatment for the adverse events (AE). The patient recovered from both the events on an unspecified date in Jan2021. Information on the batch/lot number has been requested.

Other Meds:

Current Illness:

ID: 0945954
Sex: F
Age:
State:

Vax Date: 01/07/2021
Onset Date: 01/08/2021
Rec V Date: 01/15/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Headache; fever; chills; shaking; underarm swelling; arm pain; muscles pain; fatigue; lighheadness; This is a spontaneous report from a non-contactable Other Health Professional (patient). A 25-year-old female patient (not pregnant at the time of vaccineation) received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number EL1283), via an unspecified route of administration at left arm on 07Jan2021 12:00 at single dose for COVID-19 immunization at a hospital. The patient's medical history and concomitant medications were not reported. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) for COVID-19 immunization on an unspecified date at a hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination, and had not been tested for CPVOD-19 since the vaccination. On 08Jan2021 01:00, the patient experienced headache, fever, "chills/shaking", underarm swelling, arm pain, muscles pain, fatigue, and "lighheadness". The above mentioned events resulted in doctor or other healthcare professional office/clinic visit. No treatment was received for the events. The outcome of the events was recovering. The reporter considered the events as non-serious. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 0945955
Sex: F
Age:
State: MI

Vax Date: 01/08/2021
Onset Date: 01/08/2021
Rec V Date: 01/15/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Lightheaded; Tachycardia; Blotchy rash; This is a spontaneous report from a contactable nurse (patient herself). A 34-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection; lot number: Ek9231, expiration date was unknown), intramuscularly on the left arm on 08Jan2021 (at 11:00 PM as reported; pending clarification) at a single dose for COVID-19 immunization administered at the hospital. Relevant medical history included that the patient had known allergies to medications, food, or other products, but was not specified. Concomitant medications included ascorbic acid (VITAMIN C), ergocalciferol (VITAMIN D), curcuma longa (TURMERIC) as supplement, and an unspecified multivitamin. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 08Jan2021 (at 11:15 AM as reported; pending clarification), the patient experienced lightheaded, tachycardia, and blotchy rash, which resulted in an emergency room/department or urgent care visit. The reporter assessed the events as non-serious. Therapeutic measures were taken as a result of lightheaded, tachycardia, and blotchy rash, which included diphenhydramine (BENADRYL) and steroid. The patient was recovering from all the events.

Other Meds: VITAMIN C [ASCORBIC ACID]; VITAMIN D [ERGOCALCIFEROL]; TURMERIC [CURCUMA LONGA]

Current Illness:

ID: 0945956
Sex: F
Age:
State: WI

Vax Date: 01/08/2021
Onset Date: 01/08/2021
Rec V Date: 01/15/2021
Hospital:

Lab Data:

Allergies:

Symptoms: difficulty breathing and stridor; difficulty breathing and stridor; noises on inspiration; dizziness; headache; sore throat; Anaphylaxis developed within 2 hours of injection; This is a spontaneous report from a contactable other health professional (patient). A 57-year-old female patient (not pregnant) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number EL0142), via an unspecified route of administration in arm left on 08Jan2021 09:00 at single dose for covid-19 immunisation. Medical history included Idiopathic Angioedema, Hypothyroidism. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not have COVID tested post vaccination and did not have COVID prior vaccination. The patient's concomitant medications were not reported. Reported Event: Anaphylaxis developed within 2 hours of injection. 9:00 am injection; 9:05 am Developed sore throat, 9:20 am Developed dizziness and headache, 10:00 am developed noises on inspiration, 10:20 am Presented to Emergency Services, 10:40 am IV (intravenous) diphenhydramine (BENADRYL) and dexamethasone (DECADRON), 10:45 am difficulty breathing and stridor, 11:00 am intramuscular Epinephrine, 11:10 am Racemic Epi Nebulizer, 11:20 am Breathing improved, 14:00 Discharged home. The adverse events result in Emergency room/department or urgent care. The outcome of all the events was recovering.; Sender's Comments: A possible causal association between administration of BNT162B2 and the onset of anaphylaxis reactions considering the plausible temporal relationship and the known adverse event profile of the suspect product. The underlying predisposing condition included Idiopathic Angioedema. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Other Meds:

Current Illness:

ID: 0945957
Sex: F
Age:
State: NC

Vax Date: 01/06/2021
Onset Date: 01/06/2021
Rec V Date: 01/15/2021
Hospital:

Lab Data: Test Date: 20210107; Test Name: Temperature; Result Unstructured Data: Test Result:102-102.4 Fahrenheit; Comments: Temperature of 102-102.4 degrees Fahrenheit

Allergies:

Symptoms: Nauseous; threw up a little; she keeps falling down, has had 3 falls; hit her head; she has a huge bump on her face that is very painful; she cannot walk straight or without assistance anymore; Vertigo; Weakness in the muscles; a little arm soreness; Body aches; Chills; Could not sleep; Fever; This is a spontaneous report from a contactable nurse (patient). A 52-year-old female patient received the second dose of BNT162B2 (Pfizer BioNTech COVID-19 Vaccine), Batch/lot number: EK9231, Expiry Date: 31Mar2021, via an unspecified route of administration on 06Jan2021 09:00 at single dose in deltoid right for COVID-19 immunisation. Medical history included heart attack from Jul2019. Concomitant medication included diltiazem from 2019 and ongoing at 120mg tablet taken daily for abnormal heart rhythm she did not know of until had heart attack, acetylsalicylic acid (BABY ASPIRIN) from 2019 and ongoing at 81 mg tablet taken daily for heart attack. The patient previously received the first dose of BNT162B2 via an unspecified route of administration on 17Dec2020 for COVID-19 immunisation; she got the Flu vaccine every year and got shingles vaccine in Mar2020 for immunization. She did totally fine after receiving Flu vaccines and the Shingles vaccine. She had no side effects from the Flu vaccines except maybe a little arm soreness; she had arm soreness for a couple of days after the shingles vaccine; maybe a slight fever and took it easy. This Emergency Room Nurse (patient) received her second dose of Pfizer BioNTech COVID-19 Vaccine on 06Jan2021 around 9:00am. She went back to work, worked around 6-8 more hours that day and was fine. She went home and around 8-10 hours after she got the second dose on the evening of 06Jan2021 she had a little arm soreness and body aches. Last night all night she had chills; she could not sleep; fever. This morning: 07Jan2021 she was so nauseous that she got up and tried to get to the bathroom where she threw up a little. She reported as of 07Jan2021 she kept falling down: She fell in the bathroom this morning first when she was trying to get to the bathroom to throw up; During the second fall she was going on the stairs and fell, and hit her head; she had a huge bump on her face that was very painful now that she thought was from that second fall; and she had the third fall this evening; she cannot walk straight or without assistance anymore, she had been on the couch all day. She has had vertigo all day and weakness in the muscles. Chills was described as unbearable, heavy chills that she could not control. Fever: Temperature of 102-102.4 degrees Fahrenheit. The high fever hit around 3:00am on 07Jan2021. When her high fever hit around 3:00am she thought she would go to the emergency room but she did not want to scare her family so she stayed home and tried to pull through it. Today she took a Tylenol after she threw up this morning just to get through the day. Since she cannot walk without assistance or walk straight today that's the only lingering symptom that really worries her; she may go to the emergency room tonight if she did not get any better. She just did not want to scare her family and the emergency room was another copay cost so she really did not want to go to the emergency room at her workplace; but she may go there tonight and be kept overnight under observation. Prior to taking this second dose of Pfizer BioNTech COVID-19 Vaccine she was completely fine. She expected to have body aches, chills and fever; but she never thought the Pfizer BioNTech COVID-19 Vaccine would put her into a place where she is falling like this with the nausea and vertigo; she has never in her life had vertigo or falling like this. She reported she had no other vaccinations on the same date as Pfizer BioNTech Vaccine second dose. Has had no other vaccines in the recent past. She had never felt like this before with any other vaccines; she had never felt so weak in her muscles and never fallen down like this with any other vaccines. Seriousness criteria and outcome of all events unknown. The reporter considered all events were related to Pfizer BioNTech COVID-19 Vaccine.

Other Meds: ; BABY ASPIRIN

Current Illness:

ID: 0945958
Sex: F
Age:
State: OK

Vax Date: 01/06/2021
Onset Date: 01/08/2021
Rec V Date: 01/15/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Rash over trunk of my body; This is a spontaneous report from a contactable other healthcare professional (patient). A 56-year-old female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EK9231), via an unspecified route of administration in the left arm on 06Jan2021 at a single dose for COVID-19 immunization. There were no medical history. The patient was not pregnant at the time of vaccination. The patient have no known allergies to medications, food, or other products. Concomitant medication included cetirizine hydrochloride (ZYRTEC). The patient previously took the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK5730), intramuscular in the left arm on 16Dec2020 for COVID-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination and had not been tested for COVID-19 since the vaccination. On 08Jan2021, the patient experienced rash over trunk of her body. Therapeutic measures were taken as a result of rash over trunk of her body and included treatment with diphenhydramine (BENADRYL). Outcome of the event was recovering. The event was considered non-serious by the reporter.

Other Meds: ZYRTEC [CETIRIZINE HYDROCHLORIDE]

Current Illness:

ID: 0945959
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/15/2021
Hospital:

Lab Data:

Allergies:

Symptoms: shortness of breath; This is a spontaneous report from a contactable consumer (patient herself) via Medical Information team. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection; lot/batch number and expiration date were unknown), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient reported a side effect on the COVID-19 vaccine. On an unspecified date, she experienced shortness of breath within 24 hours and asked if it was an expected side effect or if she should consult her healthcare provider (HCP). The patient considered the event as non-serious. The outcome of the event was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0945960
Sex: F
Age:
State:

Vax Date: 01/07/2021
Onset Date:
Rec V Date: 01/15/2021
Hospital:

Lab Data:

Allergies:

Symptoms: not feeling well; headache; nausea; joint pain; This is a spontaneous report from a contactable consumer (patient herself) via Medical Information team. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection; lot/batch number and expiration date were unknown), via an unspecified route of administration on 07Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient was not a healthcare professional (HCP), but she works in a healthcare facility. She had received the COVID-19 vaccine on 07Jan2021 and she was not feeling well on an unspecified date. The patient was also asking what could she take for the headache, nausea, and joint pain on an unspecified date. She also asked if her regular doctor would answer her concerns considering she had been given the vaccine at the hospital. The outcome of the events "not feeling well, headache, nausea, and joint pain" was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0945961
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/15/2021
Hospital:

Lab Data: Test Date: 2020; Test Name: covid; Test Result: Positive

Allergies:

Symptoms: flu like symptoms; right arm pit (hard and itching) swollen; right arm pit (hard and itching) swollen; fever; swollen lymph; chills; This is a spontaneous report from a contactable healthcare professional (patient). A female patient of an unspecified age (reported as 45, unit unknown) received the first dose ofBNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date: unknown), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Patient had question about getting 2nd vaccination/dose. At end of Oct2020/beginning of Nov2020, she was positive for COVID. After a month and 1/2 after COVID19, she got the vaccine. After first vaccination, 18 hours later patient had the flu like symptoms and right arm pit (hard and itching) swollen. She had fever, swollen lymph nodes at 10 or 11 O'clock. Patient had chills, fever, flu like symptoms. 18 days after, the lump was there. Outcome of the events was unknown. Patient was asking if it was okay to get the 2nd shot. Information of lot/batch number has been requested.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 134,999

Page last modified: 14 December 2021 10:42pm